🔗 Visit the ClinicalTrials.gov page for NCT01531361
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | c-Met as a Target for Personalized Therapy. | Transl Oncogenomics | 2015 | 0.92 |
| 2 | FOLFIRINOX and translational studies: Towards personalized therapy in pancreatic cancer. | World J Gastroenterol | 2016 | 0.82 |
| 3 | The minority report: targeting the rare oncogenes in NSCLC. | Curr Treat Options Oncol | 2014 | 0.78 |
| 4 | Genomic diversity of colorectal cancer: Changing landscape and emerging targets. | World J Gastroenterol | 2016 | 0.75 |